Arno Therapeutics, Inc. (OTCMKTS:ARNI – Get Free Report)’s share price passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.00 and traded as high as $0.00. Arno Therapeutics shares last traded at $0.00, with a volume of 0 shares traded.
Arno Therapeutics Price Performance
About Arno Therapeutics
Arno Therapeutics, Inc, a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company’s product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men.
Featured Articles
- Five stocks we like better than Arno Therapeutics
- How Technical Indicators Can Help You Find Oversold StocksÂ
- From PACs to Portfolios: Billionaire Bets and Investor Reactions
- Which Wall Street Analysts are the Most Accurate?
- AppLovin Stock Quadruples: What’s Behind the Bullish Sentiment?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Battle of the Retailers: Who Comes Out on Top?
Receive News & Ratings for Arno Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arno Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
